Market Cap 95.54M
Revenue (ttm) 17.59M
Net Income (ttm) -21.69M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -123.31%
Debt to Equity Ratio 0.00
Volume 2,050,400
Avg Vol 1,855,406
Day's Range N/A - N/A
Shares Out 46.15M
Stochastic %K 15%
Beta 0.53
Analysts Sell
Price Target $4.00

Company Profile

MindWalk operates as an AI-driven biotherapeutic research, technology, and scientifically robust life science company. It discovers and develops customized and novel antibodies by generating proprietary and patented processes, procedures, and innovative approaches to antibody discovery, development, and production. The company was formerly known as ImmunoPrecise Antibodies Ltd. and changed its name to MindWalk in September 2025. The company was incorporated in 1983 and is headquartered in Austin...

Industry: Biotechnology
Sector: Healthcare
Phone: 800-620-4187
Address:
Industrious 823 Congress Ave, Suite 300, Austin, United States
Latest News on IPA
No data available.